mesowatch-logo
mesowatch
Patricia Shelton

Reading Time: 13 mins

Published On: March 6, 2024

Page Features:13 cited research

Patricia Shelton - author

Dr. Patti Shelton reviews medical information on the site for accuracy. She holds both a Doctor of Medicine degree as well as a Bachelor’s degree in neuroscience from the University of Washington in Seattle. Her work focuses on communicating scientific information to the public and helping make complex concepts understandable so that patients can make their own informed decisions. She also teaches anatomy and physiology courses at the college level.

Jump to a topic


Related Pages

divider

warning icon

Find out if you qualify for a mesothelioma lawsuit.

Mesothelioma Treatment

Mesothelioma Treatment

Patricia Shelton

Reading Time: 13 mins

Published On: March 6, 2024

Page Features:13 cited research

Patricia Shelton - author

Dr. Patti Shelton reviews medical information on the site for accuracy. She holds both a Doctor of Medicine degree as well as a Bachelor’s degree in neuroscience from the University of Washington in Seattle. Her work focuses on communicating scientific information to the public and helping make complex concepts understandable so that patients can make their own informed decisions. She also teaches anatomy and physiology courses at the college level.

Jump to a topic


warning icon

Find out if you qualify for a mesothelioma lawsuit.

13 References

divider

VIEW 0 MORE REFERENCES

Related Content

divider
WHO Labels Talc as ‘Probably Carcinogenic,’ Raising Cancer Concerns
WHO Labels Talc as ‘Probably Carcinogenic,’ Raising Cancer Concerns

Mary Pieper
3 mins read - July 8, 2024

The World Health Organization on Friday stated talc is “probably carcinogenic,” based on a study by the WHO’s International Agency for Research on Cancer (IARC).The study,...

Awareness

Promising Immunotherapy Case for Peritoneal Mesothelioma
Promising Immunotherapy Case for Peritoneal Mesothelioma

Mary Pieper
2 mins read - July 5, 2024

Frontiers in Oncology provisionally accepted a case report Friday suggesting the use of first-line nivolumab and ipilimumab could be more effective than chemotherapy in malignant...

Treatment

Judge Rejects J&J’s Fraud Allegations in Mesothelioma Talc Study Case
Judge Rejects J&J’s Fraud Allegations in Mesothelioma Talc Study Case

Mary Pieper
4 mins read - July 2, 2024

A scientist has scored a victory over Johnson & Johnson, which alleged her influential research linking asbestos-contaminated cosmetic products to the deadly cancer...

Settlements

Information provided by Mesowatch aims to provide legal and financial assistance and should not be considered a substitute for medical advice, treatment or diagnosis. Past performance and settlements do not guarantee or indicate the outcome of an individual case. Viewing this information or interacting with this website does not create an attorney-client relationship. DMCA.com Protection Status